Our latest paper is out! In collaboration with @DrAnneCarpenter, we conducted a systematic high-content screen to understand the role of protein mislocalization in diverse human disorders. 1/ cell.com/cell/fulltext/S0092…
Graduate student Jack Li's work out in Molecular Cell now: By conducting a screen of 341 splicing factors, Jack identified RBM25 coupled to dCasRx as a superior tool to boost inclusion of endogenous exons /1
Graduate student Jack Li's work out in Molecular Cell now: By conducting a screen of 341 splicing factors, Jack identified RBM25 coupled to dCasRx as a superior tool to boost inclusion of endogenous exons /1
Our paper on functional discovery of protein degradation and stabilization effectors with proteome-scale induced proximity screens is out in its final version! 1/ nature.com/articles/s41586-0…rdcu.be/dBUju
early winter @newlimit:
- >10X more reprogramming factor sets tested than ever before
- >2M cells profiled, 10TB of raw seq data
- 3 team members
- 2X speed up in reprogramming library build times
- 1 cell types on our Engine
- 1st rejuvenating hits
📜 Happy to share our recent preprint featuring ORFtag - a versatile, easy and cost-effective method for probing protein function at a proteome scale. This work is the result of a collaborative effort by the @stark_lab, @AmeresSL, @EllingUlrich and @juliusbrennecke labs. 1/2
2023 @newlimit:
- 50X more reprogramming factor sets tested than the field before us
- 20X factor demultiplexing performance (reading), 7X factor delivery (writing)
- 2X team size
- 3 functional assays for immunology program
- 2 in silico model metrics > SOTA
blog ⬇️
early autumn @newlimit:
- 6X'd the # of reprogramming factors we've tested
- >4X'd signal-to-noise for our core pooled screening assay
- shortened feedback cycles by 40%
- improved in silico reprog models >30%
all covered in our latest blog
Our latest preprint is out! In a fun collaboration with @DrAnneCarpenter, we conducted a systematic high-content screen to understand the role of protein mislocalization in diverse human disorders. 1/8
biorxiv.org/content/10.1101/…
Ever wondered if you could read 100s of metabolites and drugs in parallel using a @illumina or a @10X platform? But metabolites aren’t nucleic acids — how can that work? Check out our new preprint and read on for a thread:
biorxiv.org/content/10.1101/….
New preprint! 🗞️ We used pooled protein screens to develop compact human transcriptional effectors that work across diverse biological contexts to activate or silence gene expression
biorxiv.org/content/10.1101/…
last month @newlimit:
- 1st reprogramming screens in primary cells
- Immunology team 3X'd
- 1st model-driven hypotheses
this month:
- improving screen efficiency: more exps/{$, time}
- multi-modal in silico reprogramming models
all this & more in our April update ⬇️
Our paper on 14-3-3 proteins and their role in protein aggregation and phase separation is out! This paper represents the main PhD thesis work by my student Dmitri Segal. 1/ cell.com/molecular-cell/full…
last month @newlimit:
- largest partial reprogramming screen yet
- 50% more TFs to test
- first in silico reprogramming models
this month:
- screens in old donor cells
- library rebuild -- 10X manufacturing efficiency
- automating screen analysis to shorten DBTL loops